Intuitive Surgical | ISRG - Ebitda


Intuitive Surgical reported $1.09B in EBITDA for its fiscal quarter ending in December of 2025.





Ebitda Change Date
Abbott USD 3.27B 178M Dec/2025
Agilent USD 456M 84M Dec/2025
Avanos Medical USD 13M 3M Dec/2025
Baxter International USD -447M 873M Dec/2025
Becton, Dickinson and Co. USD 1.71B 433M Dec/2025
Boston Scientific USD 1.16B 213M Dec/2025
Charles River Laboratories USD 229.8M 28.26M Mar/2026
CONMED USD 56.39M 23.97M Mar/2026
Danaher USD 1.92B 204M Mar/2026
Dentsply International USD 129M 6M Mar/2026
Dexcom USD 364.5M 57.7M Mar/2026
Edwards Lifesciences USD 70.1M 394.2M Dec/2025
Globus Medical USD 280.46M 27.86M Dec/2025
Illumina USD 469M 137M Dec/2025
Insulet USD 181.7M 12.3M Mar/2026
Integra LifeSciences USD 76.18M 28.03M Mar/2026
Intuitive Surgical USD 1.09B 165.5M Dec/2025
J&J USD 7.19B 2.32B Dec/2025
Masimo USD 85.5M 6.4M Mar/2026
Medtronic USD 2.81B 119M Mar/2026
Mettler Toledo International USD 278.99M 100.24M Mar/2026
Olympus JPY 43.41B 2.31B Mar/2026
Revvity USD 272.91M 24M Mar/2026
Steris USD 394.7M 5M Dec/2025
Stryker USD 1.57B 618M Mar/2026
Teleflex USD 247.07M 575.88M Dec/2025
Thermo Fisher Scientific USD 2.7B 464M Mar/2026
Waters USD 380.97M 85.83M Dec/2025
Zimmer Biomet Holdings USD 759M 120.8M Dec/2025